Monthly Archives: November 2021

Technology: Computer

The Netherlands Pavilion Announces 70 Companies Showcasing Tech for a Responsible Future

Leave a comment


Netherlands in the USA

Our aim is to accelerate sustainable change in a wide range of fields, from climate change and clean energy, health and wellness, hyperloop and electric vehicles, data security and more.


AMSTERDAM (PRWEB)

Returning for their sixth consecutive year, The Kingdom of the Netherlands, today announced the delegation of 70 startups and scale-ups that will take part January 5 – 8 in the Netherlands (NL Tech) Pavilion at CES 2022, the global stage for innovation. The NL Tech Pavilions are dedicated spaces intended to foster collaboration, broker valuable partnerships and introduce groundbreaking NL tech solutions that solve global challenges across a wide berth of tech categories. For the sixth consecutive year, the Netherlands will showcase its tech solutions for a responsible future. Preview the CES 2022 NL Tech Pavilion companies here.

“The Netherlands is home to some of the world’s most forward-thinking technology innovators who are creating responsible tech solutions, products and services that will help shape the future in sustainability, circularity, IoT, digital health and more,” said Gary Shapiro, Consumer Technology Association (CTA)® president and CEO. “We are honored to welcome them back to CES in 2022, and look forward to having them share their ideas and inspire an eager global audience.”

The 50 startups and 20 scale-ups feature companies solving global challenges including: sustainability and resilience, AI, robotics and quantum computing, health and wellness, smart cities and smart homes, smart mobility and vehicle tech, data security and big data. The Netherlands Startup Pavilion will be located in the Venetian Expo, downstairs in Eureka Park (Hall G, Booth 61928), and the Netherlands Scale-up Pavilion will be located upstairs in the Venetian Expo at (Halls A-C, Booth 50833).

“The Netherlands continues to pave the way and push boundaries by creating tech for a responsible future,” said HRH Prince Constantijn van Oranje, Special Envoy to Techleap.nl and the Netherlands. “Our aim is to accelerate sustainable change in a wide range of fields, from climate change and clean energy, health and wellness, hyperloop and electric vehicles, data security and more. CES offers an outstanding opportunity for our 70 Dutch start-ups and scale-ups to connect with like-minded tech entrepreneurs, expand their networks and create new business opportunities.”

The NL Tech Pavilion companies participating at CES 2022 include:

SUSTAINABILITY AND RESILIENCE:

  • Blue Heart Energy: A thermoacoustic technology that radically improves the performance of heat pumps.

  • Caeli: Worldwide air quality mapping and monitoring via satellites.

  • Circularise: Facilitates a shift to a circular economy by digitising and tracing materials across complex supply chains on a public blockchain without risking confidentiality.

  • Dayrize: A unique online consumer marketplace for sustainable products, with a mission to bring consumption within “planetary boundaries.”

  • Expivi: Interactive 3D and AR for personalized e-Commerce. (Scaleup)

  • Ferr-Tech: Sustainable and efficient wastewater treatment using Ferrate(VI), enabling reuse of water in industrial processes. (CES Innovation Award Honoree)

  • Hydraloop: Award-winning smart, decentralized, self-cleaning greywater recycling products for homes, office buildings, hotels, student housing, sports clubs and more. (Scaleup)

  • iXora: A closed, immersive cooling module for data centers that ensures 20-30% power usage savings compared to traditional air-cooled racks.

  • Incooling: Cooling down the planet, one server at a time.

  • Leap: Allows every connected device to help balance the grid, and get paid for it. Access wholesale markets through a single API and help build the flexible, renewable grid of the future.

  • Nowi: A semiconductor company that specializes in the development of energy harvesting power management technology. (Scaleup and CES Innovation Award Honoree)

  • Ocean Grazer: Energy storage system for (offshore) wind farms and other renewable energy sources. (CES Innovation Award Winner)

  • Orbisk: A fully automatic food waste monitor using AI image recognition that gives hotels, restaurants and cafés the ability to reduce food waste up to 50%.

  • RanMarine Technology: WasteShark, a floating autonomous drone that cleans pollution from waterways and collects water quality data. (CES Innovation Award Honoree)

  • SenseAnywhere: Temperature monitoring solutions for the pharmaceutical and food industries, including the safe distribution and storage of COVID-19 vaccines across Europe. (Scaleup)

  • Tapp.online: Making paper smart and interactive by integrating sensors, printed batteries and microchips. 100% recyclable paper measures, remembers and transmits temperature, shocks and humidity data throughout the supply chain.

  • TXTOmedia: Automatically transform an organization’s existing, text-based support content into dynamic how-to videos and interactive media at scale.

HEALTH AND WELLNESS:

  • AirBliss+: The most comfortable, smart anti-pollution mask for consumers and businesses.

  • Absolute Audio Labs: Powering high-definition audio hearing aids. (Scaleup and CES Innovation Award Honoree)

  • AlphaBeats: An app that turns your smartphone or wearable device into a biosensor; AI-powered biofeedback signals enhance your favorite music — as you relax, music fidelity increases.

  • CAREANIMATIONS: Solutions for comprehensible medical information that helps care providers to provide patients with easy-to-understand and tailored information to improve treatment adherence and self-management. (Scaleup)

  • Crescent Medical: A head-camera built for, and with, surgeons that makes surgical live streaming easy. (Scaleup and CES Innovation Award Honoree)

  • Picoo: Picoo One is the first game console to play outside, providing screen-free and interactive gaming for children ages 6-12.

  • Ivy Medical: A portable IV that allows patients free movement during their recovery.

  • Jawsaver: Smart earbuds to stop teeth grinding and clenching.

  • LifeSense Group: Digital health continence solutions using wearable sensors and smart textiles. (Scaleup)

  • Light Tree Ventures: Lumaflex, the first flexible, powerful, red light panel created to aid in muscle recovery following training or to treat injuries and chronic pain.

  • LoCoMoGo: The toy train that teaches children coding through play.

  • Neurocast: True passive patient monitoring.

  • Nostics: Instant, accessible and reliable testing for viruses and bacteria, including a three-minute Covid-19 test.

  • PitchPerfect: A smart sensor for baseball pitchers that acts as a digital coach.

  • PodoPrinter: SOLE, 3D-printed, flexible medical insoles.

  • RetinaScope: A handheld, low cost retinal imaging device to empower AI-based screening for Diabetic Retinopathy, Glaucoma and Age Related Macular Degeneration.

  • Scentronix: Creating one-of-a-kind perfumes for every human. Algorithmic Perfumery is the AI-supported personalized perfume platform.

  • Sencure: Enabling a new generation of medical wearables that are smaller and more accurate through chips and supporting technology.

  • Steambox: The first self-heating lunchbox to use steam innovation and smart technology.

  • Taem.io: Data driven team optimization.

  • Tover: Evidence-based game-system that improves the quality of life of dementia patients. (Scaleup)

  • TrueKinetix: Disrupting indoor sports using a patented robotics platform, enabling the best indoor experience of outdoor sports.

SMART CITIES AND SMART HOMES:

  • insmart: A single platform for all HVAC devices that monitors from the consumer’s home and improves service engineer efficiency.

  • PeopleFlows: Organize the flow of people using facial recognition to provide events with contactless control management and ensure Covid-19 measures.

  • Tekle Holographics: Customized holographic solutions for enterprise. (Scaleup)

  • Urban Mobility Systems: A developer and manufacturer of BEVs (battery electric vehicles) and electrification systems for construction equipment enabling zero-emission transport and construction. (Scaleup and CES Innovation Award Honoree)

  • VideowindoW: Transform any glass surface into a transparent video display for dynamic glare control. (CES Innovation Award Winner)

SMART MOBILITY AND VEHICLE TECH:

  • Brekr: Model B, a highly customizable electric bike with a classic, rugged design.

  • Hardt Hyperloop: A world where distance does not matter — a 10,000 kilometer hyperloop network crossing national borders. (Scaleup)

  • Routescanner: Routescanner, the first global platform that provides insight into all routes for worldwide container transport and helps users to find, compare and choose the best options.

  • E-LIFT: Smart and sustainable charging solutions. E-Lift’s charging stations can be linked to any other smart hardware device or software solution.

5G AND INTERNET OF THINGS:

  • Addoptics: Micron accurate and nanometer smooth 3D printing for high precision optical products.

  • Capte: IOT monitoring for the transportation industry. Now public and private bussing companies can make use of their mixed fleet effectively.

  • Dimenco: Simulated Reality – interacting with 3D objects in a virtual environment, without the need of any wearables. (Scaleup and CES Innovation Award Honoree)

  • EZ Factory: A simple, visual software platform for factories to digitize procedures and improve safety and efficiency on the shop floor.

  • Hiber: The world’s first global IoT satellite network to help it to deliver cost-effective, easy-to-use products, including HiberHilo for oil and gas well integrity monitoring, and HiberEasypulse for asset tracking and fleet monitoring. (Scaleup)

  • Hyfen: Connecting the pension industry on a secure and efficient platform.

  • InPhocal: A unique, concentric laser beam that reduces the need for ink and is 2.5 times faster than printing. (CES Innovation Award Honoree)

AI, ROBOTICS AND QUANTUM COMPUTING:

  • Avular: Ready-to-fly drones and ready-to-drive rovers using a modular robot ‘brain’ and reconfigured modular robot platforms that allow companies to quickly and efficiently develop new mobile robots. (Scaleup and CES Innovation Award Honoree)

  • BrainCreators: Digital Inspectors that reduce cost and improve consistency at an unrivaled speed. Human inspectors can now train their digital counterparts on our award-winning AI-powered software. (Scaleup)

  • EdgeLeap: Smart AI assistants working along with you to surface business relevant insights.

  • Datacadabra: Digital intelligence that enables you to work more efficiently. (Scaleup)

  • DeltaProto: Builders of the best pick-and-place cobot (collaborative robot) for proto PCB assembly in the world.

  • Lalaland.ai: AI-fashion models with real emotions. e-Commerce brands can make their models as diverse and one-of-a-kind as their target audience.

  • LioniX International: A leading global provider of customized microsystem solutions specializing in integrated photonics and customized MEMS devices. (Scaleup)

  • Mission Control Lab: The creators of Inventure Kits (invention + adventure), educational STEAM boxes with all of the materials inside.

  • Morphotonics: Develops and sells roll-to-plate (R2P) OEM production technology for imprinting nano- or microstructures on extremely large area substrates. (CES Innovation Award Honoree)

  • QuiX Quantum: Integrated photonics for optical quantum computing.

  • SenseGlove: Force and haptic feedback gloves that enable professionals to physically interact with virtual objects for VR training and research purposes. (Scaleup)

DATA SECURITY AND BIG DATA:

  • Prowise: Touchscreens and instructional, adaptive AI software packages for education, business and government.

  • Red Kubes: A full platform experience for Kubernetes with an intuitive desktop-like user interface and ready to use pre-configured built-in applications to offer an out-of-the-box experience. (Scaleup)

  • Roseman Labs: Creates new data business models that transform how organizations handle sensitive data, with unprecedented compliance, privacy and rapid deployment. (CES Innovation Award Honoree)

Interested media and analysts, please contact NLatCES2022@wearemgp.com to schedule an interview before or during CES 2022.

About The Kingdom of the Netherlands

The Netherlands strives to solve societal and economic challenges with local and international partners. A highly innovative country, The Netherlands ranks fourth on the World Economic Forum Global Competitiveness Index, sixth on the Global Innovation Index, and Amsterdam is the number three startup ecosystem in Europe. As a trading nation, it has continuously ranked as one of the top four foreign investors in the US for multiple years. More than 825K jobs in the United States are the result of the strong economic relations with the Netherlands. Learn more at http://www.NLintheUSA.com

Through Holland in the Valley, the Dutch ecosystem in the Bay Area, the Consulate General of the Netherlands in San Francisco empowers Dutch entrepreneurs and talent to innovate and scale in the US by offering a network, content and programs.

All trademarks used herein are the property of their respective owners.

Share article on social media or email:

Health

The Quinism Foundation Reemphasizes the Need for Caution in the Investigational and Off-Label Use of Tafenoquine Against COVID-19

Leave a comment



WHITE RIVER JUNCTION, Vt. (PRWEB)

The Quinism Foundation has again called on clinical researchers and prescribers to exercise caution in the investigational and off-label use of tafenoquine against COVID-19, following an announcement by 60 Degrees Pharmaceuticals (“60P”), the marketers of Arakoda®-branded tafenoquine, [1] of a decision by a Data Safety Monitoring Board to recommend continuation of a clinical trial funded by 60P and the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, [2] evaluating the safety and efficacy of the drug for treatment of mild-moderate COVID-19 disease in adults aged 18 years of age or older. [3]

“As its ‘quine’ suffix indicates, tafenoquine is a quinoline antimalarial drug structurally related to hydroxychloroquine and chloroquine,” said Dr. Remington Nevin, MD, MPH, DrPH, a former U.S. Army public health physician and Johns Hopkins-trained psychiatric epidemiologist and drug safety expert, who now serves as Executive and Medical Director of The Quinism Foundation.

“All quinoline antimalarial drugs are amphiphilic and diprotic weak bases, which lead to their accumulation in acidic cellular endosomes, the property thought to at least partly underlie the observed antiviral activity of certain previously-tested drugs,” said Dr. Nevin. [4,5]

“Unfortunately, as experience with hydroxychloroquine and chloroquine has shown, the same common properties that likely underlie the observed effectiveness of these quinoline antimalarial drugs in-vitro against the virus may also underlie their common dangers,” said Dr. Nevin.

“In susceptible individuals, these drugs act as idiosyncratic neurotoxicants, potentially causing irreversible brain and brainstem dysfunction, even when used at relatively low doses,” said Dr. Nevin. “This drug-induced dysfunction causes a disease of the brain and brainstem called quinoline encephalopathy, or quinism, which can be marked by lasting psychiatric and neurological symptoms including tinnitus, dizziness, vertigo, paresthesias, visual disturbances, nightmares, insomnia, anxiety, agoraphobia, paranoia, psychosis, cognitive dysfunction, depression, personality change, and suicidal thoughts, among others,” said Dr. Nevin. [6]

“In recognition of tafenoquine’s neuropsychiatric liability, the FDA has required language in the approved U.S. drug label for Arakoda® warning of a risk of severe psychotic reactions, and that those taking the drug should be promptly evaluated by a medical professional if psychiatric symptoms occur during use, such as changes in mood, anxiety, insomnia, and nightmares if they are moderate and last more than three days or are severe.” [7]

Although the unpublished research paper accompanying 60P’s original announcement of its clinical trial [8] suggests “proof of hope” for tafenoquine against COVID-19, in other words, an “expectation that pharmacologically relevant concentrations… can be achieved clinically and a likelihood that a relevant therapeutic index exists,” [9] Dr. Nevin notes that tafenoquine’s neurotoxicity may significantly narrow the drug’s therapeutic index for this proposed indication.

“In U.S. Army research conducted prior to 60P’s commercialization of tafenoquine, the drug was found to be the most neurotoxic quinoline among six tested, including mefloquine and chloroquine, and in cultured embryonic rat neurons, exhibited an IC50 of 12.1 µM,” said Dr. Nevin. [10] “This is less than threefold the concentration of 5.1 µM exhibiting EC90 against SARS-CoV-2 in VERO E6 cells in 60P’s unpublished research paper.” [9]

“While these results suggest promise against COVID-19, experience with chloroquine and hydroxychloroquine should temper institutional interest in similar investigational use of tafenoquine,” said Dr. Nevin. “Likewise, to ensure adequate informed consent, patients enrolled in the clinical trials underway must also be informed of tafenoquine’s inherent neurotoxicity and neuropsychiatric liability.”

“As has been seen from popular interest in another anti-parasitic drug, ivermectin, prescribers may be approached by patients seeking alternatives to FDA-approved medications for prevention and treatment of COVID-19,” said Dr. Nevin. “Particularly given the availability of FDA-approved vaccines and medications for these indications, prescribers should exercise caution against the ill-advised off-label use of either Arakoda®- or Krintafe®-branded tafenoquine, neither of which is FDA-approved for prevention or treatment of COVID-19.”

“With international travel to malaria-endemic areas all but eliminated during the pandemic, and with significantly reduced demand for antimalarial drugs within the U.S. market as a result, such off-label use of Arakoda® could risk becoming the dominant reason for the drug’s prescribing,” said Dr. Nevin. “We encourage 60P to work with FDA, and to be transparent in sharing and monitoring its sales data with interested parties, to ensure the drug is not being widely prescribed for this reason, contrary to its FDA-approved antimalarial indications.”

Dr. Nevin also emphasized the importance of recognizing and properly reporting suspected adverse effects from use of tafenoquine, including when the drug is used off label against COVID-19. “While it may be tempting to attribute anxiety, depression, paranoia, or other mental health symptoms to the psychological effects of the COVID-19 pandemic,” said Dr. Nevin, “these symptoms, if they occur during attempted off-label use in prevention or treatment of disease, may be an early warning sign of idiosyncratic quinoline neurotoxicity. Likewise, more severe neuropsychiatric symptoms, including confusion or psychosis, may not necessarily be merely neurologic complications of the disease, but may represent potentially lasting adverse effects from the use the drug.”

Dr. Nevin noted that suspected adverse effects from tafenoquine and related quinoline drugs may be reported to the U.S. Food and Drug Administration’s MedWatch program, at

https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program.

About The Quinism Foundation

The Quinism Foundation, founded in January 2018, in White River Junction, Vermont, promotes and supports education and research on quinism, the family of medical disorders caused by exposure to quinoline drugs, including tafenoquine, chloroquine, hydroxychloroquine, and mefloquine.

Dr. Nevin is a board-certified occupational medicine and preventive medicine physician and former U.S. Army medical officer and epidemiologist. He is author of more than 30 scientific publications on malaria and the quinoline antimalarials, including “Neuropsychiatric Quinism: Chronic Encephalopathy Caused by Poisoning by Mefloquine and Related Quinoline Drugs,” published in the Springer Nature book, “Veteran Psychiatry in the US.”

(https://link.springer.com/chapter/10.1007/978-3-030-05384-0_20).

References

1. 60 Degrees Pharmaceuticals, LLC. Data Safety Monitoring Board Recommends Completion of Phase II Study to Evaluate the Efficacy and Safety of ARAKODA® (tafenoquine) for Treatment of Mild-Moderate Covid-19 Disease. October 12, 2021. Available at: https://www.prnewswire.com/news-releases/data-safety-monitoring-board-recommends-completion-of-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-arakoda-tafenoquine-for-treatment-of-mild-moderate-covid-19-disease-301398568.html

2. Department of Defense. PEO-CBRND Investment Initiates Phase II Clinical Trial Using Tafenoquine to Treat COVID-19. March 12, 2021. Available at: https://www.jpeocbrnd.osd.mil/Media/News/Article/2547624/jpeo-cbrnd-investment-initiates-phase-ii-clinical-trial-using-tafenoquine-to-tr/

3. 60 Degrees Pharmaceuticals, LLC . Tafenoquine in Patients With Mild to Moderate COVID-19. ClinicalTrials.gov Identifier: NCT04533347. Available at: https://clinicaltrials.gov/ct2/show/NCT04533347

4. Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology journal. 2005;2:69.

5. Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinical infectious diseases. 2020;7:732-739.

6. Nevin RL. Neuropsychiatric Quinism: Chronic Encephalopathy Caused by Poisoning by Mefloquine and Related Quinoline Drugs. In: Ritchie EC, Llorente MD, eds. Veteran Psychiatry in the US. Cham: Springer International Publishing; 2019:315-331.

7. 60 Degrees Pharmaceuticals. Arakoda (tafenoquine) Prescribing Information. August 2018. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210607lbl.pdf

8. 60 Degrees Pharmaceuticals, LLC. 60 Degrees Pharmaceuticals Announces Positive Results of Cell Culture Testing of ARAKODA® (tafenoquine) for COVID-19. July 14, 2020. Available at: https://www.businesswire.com/news/home/20200714005355/en/60-Degrees-Pharmaceuticals-Announces-Positive-Results-of-Cell-Culture-Testing-of-ARAKODA®-tafenoquine-for-COVID-19

9. Dow GS, Dc W, Fenner J, Yeo KR. Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro. 2020. bioRxiv 2020.07.12.199059. Available at: https://doi.org/10.1101/2020.07.12.199059

10. Agboruche RL. 529.3 In-Vitro Toxicity Assessment of Antimalarial Drug Toxicity on Cultured Embryonic Rat Neurons, Macrophage (RAW 264.7), and Kidney Cells (VERO-CCl-81). FASEB Journal. 2009;23(1 Meeting Abstract Supplement):529.3.

health and fitness

National Conscience Month Originator Explains How Your Heart, Liver, Brain and Kidneys Can Also Celebrate Thanksgiving This Year

Leave a comment


Leonard Perlmutter
Originator of Conscience Month

“When we use our Conscience as our guide during the holidays, the positive benefits impact every mind and body sitting around the table.” Leonard Perlmutter (Ram Lev)


AVERILL PARK, N.Y. (PRWEB)

As families and friends gather around the Thanksgiving dinner table in gratitude for life’s many blessings, Leonard Perlmutter, founder of American Meditation Institute reminds the nation that celebrants can ensure that every organ of their bodies will also be able to give thanks for the wholesome pleasures of delicious, home-made food. According to Perlmutter, author of the new book YOUR CONSCIENCE, and originator of National Conscience Month (January of 2022), no individual will have to deny themself the pleasures of food nor experience guilt this Thanksgiving––if they simply experiment wisely with food choices, like deciding to eat one, rather than two or three slices of Grandma’s famous apple pie.

Perlmutter says, “If we think of Thanksgiving dinner as a scientific laboratory for experimenting with the unerring wisdom of the Conscience, we can savor every morsel we eat, while at the same time loving our muscles, nerves, joints, eyes, teeth, brain, heart, lungs, liver, bladder, intestines, stomach and kidneys just to name a few. When we use the Conscience as our guide, we’ll also find the flexibility, energy, optimism, and good sense of humor we need to help prevent the potential family conflicts that can so easily erupt at such holiday gatherings.”

Learn more about how to create all kinds of easy experiments at holiday time and every other day of the year in Perlmutter’s new book, YOUR CONSCIENCE. It teaches how to start the process of trusting one’s Inner Wisdom, even if it’s unclear where or how to start. The book is an easy-to-read handbook that presents simple experiments for practicing how to use the Conscience—and notes the many benefits that can be derived from that effort. Only through one’s personal experience of testing the wisdom of the Conscience can any individual learn to trust its ever-reliable guidance in making lifestyle choices that will assure long-term good health and happiness.

About the American Meditation Institute

The American Meditation Institute (AMI), a 501(c)3 non-profit educational organization devoted to the teaching and practice of Yoga Science and AMI meditation as holistic mind-body medicine. In its approach to wellness, AMI combines the healing arts of the East with the practicality of modern Western science. Throughout the year, The American Meditation Institute presents Leonard Perlmutter’s Foundation Course for solving all of life’s challenges, and publishes Transformation a quarterly journal of Yoga Science that contains helpful news and a complete upcoming calendar of classes.

FACEBOOK Link: https://www.facebook.com/AmericanMeditationInstitute

To schedule an interview with Leonard Perlmutter, please contact:

Media Contact:

Robert Washington

American Meditation Institute

60 Garner Road

Averill Park, NY 12018

Tel: 518.674.8714

Fax: 518.674.8714

Share article on social media or email:

Home and Family: Marriage / Relationships

ClearAngel Invests $10,000 in Experience-Centered Adult Toy Brand, Everlasting Adult Pleasure

Leave a comment


News Image

“For Everlasting Adult Pleasure, this ClearAngel investment reflects our mission of supporting the small business owner in their efforts to change the standard in their industry.” – Andrew D’Souza, CEO and co-founder, Clearco


TORONTO (PRWEB)

Clearco, the world’s largest e-commerce investor revolutionizing the way founders grow their businesses, today announced that its industry-leading ClearAngel program is funding Everlasting Adult Pleasure, an adult toy brand retailer that helps inspire people to live more fun, creative and happy lives. ClearAngel gives early-stage companies access to revenue share capital, data-driven advice, and an extensive network of apps, agencies, and investors powered by Clearco.

Founded in 2020, Everlasting Adult Pleasure focuses on top-tier, personalized customer service. The company provides lifetime warranties on all items, and founder, Christopher Davis, personally contacts customers regarding product needs. Their service has successfully made a mark on their clientele, but they’ve yet to expand operations and resources. ClearAngel will enable them to grow their network to do so.

ClearAngel is among just a few equity-free, flexible capital options for early-stage founders who lack the network to raise an angel round or join exclusive accelerators. Since its February 2021 launch, the program has already funded over 400 companies.

“We’re proud to fund Everlasting Adult Pleasure in its mission to make adult pleasure about the customer instead of the sale,” said Andrew D’Souza, CEO and co-founder, Clearco. “For Everlasting Adult Pleasure, this ClearAngel investment reflects our mission of supporting the small business owner in their efforts to change the standard in their industry.”

In addition to $10,000 of flexible capital, Everlasting Adult Pleasure will also get access to a network of more than 500 investors, growth teams, agencies, apps, lawyers, and buyers; and data-driven advice designed to help scale and hit new revenue milestones. Now that they are backed by ClearAngel, the company is excited to maximize on the network of businesses and experts to learn and continue to better service, operations, and sales to hit their first $100,000 in revenue.

“We will use Clearco’s capital to continue to create a memorable experience for our current and future customers. We will also invest in new business techniques that will help us grow,” said Christopher Davis, founder, Everlasting Adult Pleasure. “Our goal is to share the latest pleasurable adult sex toys that inspire our customers to live a more fun, creative, and happy life.”

Learn more about Everlasting Adult Pleasure and experience exceptional customer service for yourself.

ClearAngel is currently onboarding E-commerce and product companies. The program has limited spots available for SaaS, Apps, marketplace and stealth companies. To learn more about applying, visit angel.clearbanc.com.

About Clearco:

Co-founded as Clearbanc in 2015 by Michele Romanow from Canada’s Shark Tank (Dragons’ Den), Andrew D’Souza, Ivan Gritsiniak, Charlie Feng, and Tanay Delima, Clearco offers the most founder-friendly capital solutions for e-commerce, mobile apps, and SaaS founders as well as a full suite of products and access to a powerful global network, insights and data, and recommendations. Clearco has invested over $2 Billion in over 4,500 companies to date, including Leesa Sleep, fashion-rental service Le Tote, home goods company Public Goods, shirtmaker UNTUCKit, online speech therapy practice Expressible, and digital real estate marketplace SetSchedule. For more information visit clear.co and @getClearco.

Share article on social media or email:

Health

Rare Cannabinoid Company Adds Tasty, Pure Cannabinoid Edibles To Its Apothecary In Time For The Holidays

Leave a comment


Rare Cannabinoid Company's THCV, CBN, CBG, and CBD gummies in bottles and a variety packet of all gummies.

Rare Cannabinoid Company is now selling pure THCV, CBN, CBG, and CBD gummies. As an introductory offer, customers who spend $50 or more will receive a free variety packet of all of the gummies.

Since these gummies are strong, we recommend people take just half to one CBD gummy with half to one rare cannabinoid gummy – THCV, CBG, or CBN – depending on their needs.


HONOLULU (PRWEB)

Rare Cannabinoid Company has launched the world’s first pure high potency mix-and-match THCV, CBN, CBG and CBD gummies in time for holiday shopping. Each gummy contains a high amount of one pure cannabinoid. THCV gummies each contain 25mg THCV for energy and appetite suppression. CBN gummies have 30mg CBN for relaxation and sleep. CBG gummies each contain 30mg CBG for discomfort and CBD gummies each have 30mg CBD for stress resilience.

As an introductory offer, customers who spend $50 or more will receive a free Cannabinoid Variety Packet containing all of the new gummies (worth $19.95). These packets are a great way for people to try all of the gummies or give as stocking stuffer gifts this holiday season.

Rare Cannabinoid Company also offers packets of gummies in dispenser boxes for wholesale customers to sell on their store shelves or next to cash registers.

Following the brand’s apothecary concept, the gummies are intended to be combined with each other or their tinctures of CBDV, Delta-8-THC, CBDA, CBC, THCV, CBG, CBN, full spectrum Rare Hawaiian CBD, 3000mg CBD, 1:1 blends or terpene-only oils.

“Our new gummies are a tasty way for people to experience our apothecary and see which specific cannabinoids can help them,” said Rare Cannabinoid Company founder and CEO Jared Dalgamouni.

“Since these gummies are strong, we recommend people take just half to one CBD gummy with half to one rare cannabinoid gummy – THCV, CBG, or CBN – depending on their needs,” Dalgamouni said.

Rare Cannabinoid Company believes that cannabinoids work best when combined with each other or a full spectrum CBD or THC product for the entourage effect. By using single extracts of rare cannabinoids and terpenes, people can create their own bespoke formulas tailored to their exact needs. The addition of cannabinoid gummies to their apothecary opens the door to customers who prefer edibles. The gummies are vegan and are made with all natural flavorings in a cGMP-certified facility. Independent third-party lab reports are available online.

Cannabinoid gummies are sold in bottles and packets. The following options are available on their website and to wholesale clients:

THCV Gummies (4 oz. Bottle): Each yellow, lemon-flavored THCV gummy contains 25mg THCV. There are 15 THCV gummies per bottle. THCV (tetrahydrocannabivarin) acts like a stimulant, increasing energy and decreasing appetite, which may aid weight loss.

CBN Gummies (6 oz. Bottle): Each purple, huckleberry-flavored CBN gummy contains 30mg CBN. There are 30 CBN gummies per bottle. CBN (cannabinol) is considered the most sedative cannabinoid and will promote relaxation and restful sleep.

CBG Gummies (6 oz. Bottle): Each green apple CBG gummy contains 30mg CBG. There are 30 CBG gummies per bottle. CBG (cannabigerol) offers relief from soreness and discomfort and is being studied for many more potential uses.

CBD Gummies (6 oz. Bottle): Each red, strawberry-flavored CBD gummy contains 30mg CBD. There are 30 CBD gummies per bottle. CBD (cannabidiol) offers calm, balance, stress-resilience and relief from inflammation caused by daily activities and exercise. It is also ideal to combine rare cannabinoids with CBD for the entourage effect.

Cannabinoid Variety Packet: Each packet contains one 25mg THCV gummy, one 30mg CBN gummy, one 30mg CBG gummy, and three 30mg CBD gummies. These are a great way for people to test how cannabinoids affect them or give as a gift packet. For a limited time, customers who spend $50 or more when they order from rarecannabinoidco.com will receive one packet for free. Packets are otherwise sold online in bundles of three.

Rare Cannabinoid Company is also helping its more than 200 wholesale customers introduce cannabinoid gummies to their shoppers by offering more small packets of gummies in dispenser boxes. They offer THCV gummies with CBD gummies, CBN gummies with CBD gummies, and CBG gummies with CBD gummies. This is so that customers can take half to one CBD gummy along with half to one rare cannabinoid gummy depending on their need. Those looking for a boost of energy or weight control will be interested in the THCV and CBD gummies while those struggling to fall asleep will like the help of CBN and CBD, and those with aches and soreness or inflammation from activities can buy the CBG and CBD gummies. Beautifully designed dispensers can sit on stores shelves or next to cash registers for impulse purchases. To keep each packet’s retail price under $20, they each contain a different amount of gummies due to the cost difference between THCV, CBN, CBG, and CBD. The packets are as follows:

2 THCV Gummies + 2 CBD Gummies, 3 CBN gummies + 3 CBD gummies, and 4 CBG gummies + 4 CBD gummies.

The Cannabinoid Variety Packet (one of each THCV gummy, CBN gummy and CBG gummy + 3 CBD gummies) can also be purchased on its own in stores (but only in bundles of three online).

Rare Cannabinoid Company recently launched its redesigned website which makes it easy for customers to understand how CBD, rare cannabinoids, and terpenes work. People can now shop by their need, with recommended cannabinoids suggested for “Energy and Focus,” “Sleep,” “Stress Relief,” “Discomfort,” “Mood Enhancers,” “Appetite Suppression,” and “Nausea.” For example, for “Sleep,” the recommended products are CBN, Relax Terpenes, and full spectrum Rare Hawaiian CBD. There are are links to scientific and medical studies on each cannabinoid on product pages. For patients needing more specialized care, there is a directory of independent cannabinoid advisors who are familiar with hemp, cannabinoids, terpenes and Rare Cannabinoid Company’s specific products.

Rare Cannabinoid Company is an American company based in the 50th state of Hawaii. It was established in the first quarter of 2020 and is a pioneer in the “rare” or “minor” cannabinoid industry, offering purified tinctures and gummies of rare cannabinoid and terpenes as well as blends with full spectrum Hawaiian CBD.

Rare Cannabinoid Company is the sister brand of Hawaiian Choice, which was established in the fourth quarter of 2017. Hawaiian Choice is a luxury, lifestyle brand that combines premium broad spectrum Hawaiian CBD with organic and wild crafted Hawaiian fruits, essential oils and honey in an assortment of tinctures, edible jellies, topical gels, and pet products.

Stores interested in stocking Rare Cannabinoid Company and/or Hawaiian Choice products can request a wholesale account at Wellness Orders.

Society: Christianity

Leonie Stair’s newly released “The Signal of Wings” is an engaging collection of lyrical writings with a basis in the author’s faith

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“The Signal of Wings”: a powerful testament of faith and the strength found within devoted worship. “The Signal of Wings” is the creation of published author Leonie Stair, a former teacher and graduate from Sam Sharpe Teachers’ College, Jamaica, West Indies. Stair is also a graduate of Herbert H. Lehman College and a licensed nursing home administrator.

Stair shares, “The Signal of Wings is a collection of inspirational writings that provides the reader with examples of how God can make the impossible possible by having faith in him. The author’s goal is that this compilation will provide spiritual comfort to those that believe in salvation, sanctification, and life after death. The reader is provided with a spiritual guide for deliverance from troubles and trials in their life; it’s a gateway to understanding how to achieve inner peace.”

Published by Christian Faith Publishing, Leonie Stair’s new book empowers the spirit and engages the mind through a series of poetic writings.

Stair’s hopes to inspire others looking for strength and peace through a devoted spiritual life.

Consumers can purchase “The Signal of Wings” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “The Signal of Wings,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Society: Christianity

Lora Goss’s newly released “Your Walk Walks and Your Talk Talks” is an inspiring personal memoir that explores the author’s faith

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“Your Walk Walks and Your Talk Talks”: a nostalgic look back on some of the author’s most important moments. “Your Walk Walks and Your Talk Talks” is the creation of published author Lora Goss.

Goss shares, “Making decisions at any age is not always an easy feat. When you are walking with the Lord Jesus Christ, it makes sense to pray and do the next right thing. As life moves at ninety miles an hour, moving with the flow can set you up to make split-second decisions. Taking what we think is the easy way is often the hardest of all.

“We are told in 1 Peter 5:7 to cast all our cares on Him because He cares for us. Taking the Jesus way out is always the best way. It may not be the easy that we are looking for, but it will not leave the collateral damage that our way leaves behind.

“The roads that we walk down in life are covered with attractive billboards drawing us to off-ramps that will lead us to destruction. It is so important to keep our eyes fixed on Jesus Christ as we walk life’s highways and byways so we are not lured into the craziness that the world has to offer.

“Taking life one moment at a time is actually a doable thing. Life moves in seconds, not days. Don’t let one trial take you down. Romans 8:13 says that we are more than conquerors, and thankfully, God is a god of do-overs!”

Published by Christian Faith Publishing, Lora Goss’s new book lets readers take a private look into the author’s childhood, spiritual growth, and hopes for the future.

Goss shares with hopes of encouraging others to discover or rekindle a strong bond with faith and God’s love.

Consumers can purchase “Your Walk Walks and Your Talk Talks” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Your Walk Walks and Your Talk Talks,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Society: Christianity

The Life of Jesus Christ” is an artistic exploration of Jesus Christ’s life experience

Leave a comment


News Image


MEADVILLE, Pa. (PRWEB)

“Washed as White as Snow: The Life of Jesus Christ”: an inspiring series of reflections and vibrant imagery. “Washed as White as Snow: The Life of Jesus Christ” is the creation of published author Melissa N. Robertson, a daughter of God, a wife, a mother, and a macro photographer who resides in Colorado.

Robertson shares, “In this exciting sequel to the book The Good News of Jesus Christ, we are given the opportunity to learn about the life of Jesus Christ through the pictures God draws within real-life snowflakes. Author and macro photographer Melissa N. Robertson brings creative insight into the life that Jesus Christ lived and how it pertains to living out the Christian life. In this inspiring, moving, and unforgettable book, the life of a Christian is focused on that of a fisherman out fishing for new people to come and join in the grace, love, and forgiveness given by God through His Son, Jesus Christ. The book invites all people to read, remember, and learn from the life and examples of Jesus Christ so all may live a life full of understanding, joy, and peace within Christianity.

“Enjoy the journey written in the book most read throughout history, the Holy Bible, and see it come to life in a way people have never imagined. Come and learn what it means to be a Christian and a fisher of people through the life of Jesus Christ.

“For it pleased the Father that in Him all the fullness should dwell, and by Him to reconcile all things to Himself, by Him, whether things on earth or things in heaven, having made peace through the blood of His cross.

“And you, who once were alienated and enemies in your mind by wicked works, yet now He has reconciled in the body of His flesh through death, to present you holy, and blameless, and above reproach in His sight— if indeed you continue in the faith, grounded and steadfast, and are not moved away from the hope of the gospel which you heard, which was preached to every creature under heaven. (Colossians 1:19–23 NKJV)”

Published by Christian Faith Publishing, Melissa N. Robertson’s new book pairs inspiring commentary with relevant scripture.

Robertson’s infectious and joyful faith is apparent within this second installment to the author’s reflections on the life of Jesus.

Consumers can purchase “Washed as White as Snow: The Life of Jesus Christ” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Washed as White as Snow: The Life of Jesus Christ,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Health

Autism Learning Partners to Open New Location in Hickory, NC to Serve the Autism Community

Leave a comment


Autism Learning Partners - Making Progress Possible

“Our staff are committed to supporting individuals and the families we serve live more fulfilling lives. The ongoing collaboration with community partners has been instrumental in sustaining this success across environments.” Said Gina T. Chang, Ph.D., BCBA-D, CEO of ALP.


HICKORY, N.C. (PRWEB)

Autism Learning Partners (ALP) strives to give hope, support, and paths of progress for children and their families living with autism and related disorders. With their vast network of community partnerships and ever-growing list of accepted insurances, families can receive quality support. In Hickory, ALP is committed to connecting with local pediatricians and psychologists to discuss the importance of early diagnosis and intervention. ALP believes that a tailored, comprehensive care plan with a dedicated clinical team allows children and their family units to experience the most progress possible.

“Our staff are committed to supporting individuals and the families we serve to live more fulfilling lives. The ongoing collaboration with community partners has been instrumental in sustaining this success across environments,” said Gina T. Chang, Ph.D., BCBA-D, CEO of ALP.

ALP is a national leader in the special needs field for over 30 years. They are headquartered in Pasadena, CA, employs over 280 Board Certified Behavior Analysts (“BCBAs”) and has a total workforce of 3,000, including Behavior Technicians providing in-home and in-clinic ABA-based care across the country. Services include: Applied Behavioral Analysis and additionally offer speech, occupational, physical therapies, and diagnostic services in select regions. Treatment is now offered in 19 states including California, Colorado, Connecticut, Florida, Georgia, Indiana, Maryland, Massachusetts, Michigan, New Jersey, New Mexico, New York, Ohio, Oregon, Rhode Island, Texas, Utah, and Washington.

To learn more about Autism Learning Partners and its services, please visit AutismLearningPartners.com.

Share article on social media or email:

Health

COVID Vaccines Save Lives, Vaccination Appointments Can Save Time

Leave a comment


And it’s always right to treat your pharmacist and pharmacy team members with courtesy and respect – they are working hard for the health, wellness and return-to-normal for all of us.


WASHINGTON (PRWEB)

The National Association of Chain Drug Stores (NACDS) has a message that can make your COVID-19 pharmacy vaccination experience simple and smooth: check pharmacy policies – especially about appointments.

NACDS President and CEO Steven C. Anderson says:

“Pharmacy teams have helped to lead Americans through the pandemic. This is an important moment in the recovery with demands on pharmacies at an all-time high. In addition to giving some adults and teens their initial doses of COVID vaccines, pharmacy teams are giving COVID boosters and expanding to pediatric COVID vaccinations. They are giving flu vaccinations and other shots, too. And while vaccination clinics were everywhere earlier this year, the focus now is on pharmacies as the sustainable vaccination solution.

“The message of NACDS is this:


  • it’s wise to get your COVID vaccination;

  • especially in busier areas, it may be best to get an appointment for a COVID vaccination if your pharmacy offers appointments – many locations may require appointments;

  • and it’s always right to treat your pharmacist and pharmacy team members with courtesy and respect – they are working hard for the health, wellness and return-to-normal for all of us.

“Check your pharmacy’s website for information about how to book your appointment, or to learn if walk-ins are possible. Using the pharmacy’s website can help everyone get their vaccinations efficiently, and those without easy internet access can also call their pharmacy for appointment information.”

“Pharmacies and pharmacy teams are honored to serve as the face of neighborhood healthcare and have helped to lead the way throughout COVID-19. They have stayed open. They have ramped up COVID testing. They have gotten COVID and flu shots to arms efficiently, conveniently and equitably. They have provided access to other health and wellness solutions. And soon they will be a key access point for medications that treat COVID.”

NACDS represents regional and national pharmacies – from those with four stores to those operating nationally with approximately 10,000 locations. NACDS members operate pharmacies in the traditional drug store, grocery, and mass retail formats.

Share article on social media or email: